Sorafenib therapy for hepatocellular carcinoma prior to liver transplant is associated with increased complications after transplant.
Truesdale AE, Caldwell SH, Shah NL, Argo CK, Al-Osaimi AM, Schmitt TM, Northup PG. Sorafenib therapy for hepatocellular carcinoma prior to liver transplant is associated with increased complications after transplant. Transpl Int. 2011 Oct; 24(10):991-8.